Sarcopenia is characterized by an age-related loss of skeletal muscle mass and function
and has been recognized as a clinical disease by the World Health Organization since …

Sarcopenia is a condition marked by a significant reduction in muscle mass and strength,
primarily due to the aging process, which critically impacts muscle protein dynamics …

Alzheimer's disease (AD) is progressive and ultimately fatal, with current drugs failing to
reverse and cure it. This study aimed to find plant species which may provide therapeutic …

The imbalance in osteoblast (OB)-dependent bone formation in favor of osteoclast (OC)-
dependent bone resorption is the main cause of loss of tissue mineral mass during bone …

Age-associated osteosarcopenia is an unresolved syndrome characterized by the
concomitant loss of bone (osteopenia) and skeletal muscle (sarcopenia) tissues increasing …

With the rapid aging of the global population posing a serious problem, frailty, a non-specific
state that reflects physiological senescence rather than aging in time, has become more …

Inflammaging, a coexistence of inflammation and aging, is a persistent, systemic, low-grade
inflammation seen in the geriatric population. Various natural compounds have been greatly …

Sarcopenia is a progressive muscle disease characterized by the loss of skeletal muscle
mass, strength, function, and physical performance. Since the disease code was assigned …

Skeletal muscle plasticity is maintained by various ways to regulate cell and protein
turnover. When muscle atrophy occurs, proteolytic cascades are activated, resulting in the …

Duchenne muscular dystrophy (DMD) is an X-linked disease caused by mutations in DMD
gene translating in lack of functional dystrophin and resulting in susceptibility of myofibers to …